These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. BAZ2A-RNA mediated association with TOP2A and KDM1A represses genes implicated in prostate cancer. Roganowicz M; Bär D; Bersaglieri C; Aprigliano R; Santoro R Life Sci Alliance; 2023 Jul; 6(7):. PubMed ID: 37184661 [TBL] [Abstract][Full Text] [Related]
3. TIP5 primes prostate luminal cells for the oncogenic transformation mediated by Pietrzak K; Kuzyakiv R; Simon R; Bolis M; Bär D; Aprigliano R; Theurillat JP; Sauter G; Santoro R Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3637-3647. PubMed ID: 32024754 [TBL] [Abstract][Full Text] [Related]
4. BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence. Gu L; Frommel SC; Oakes CC; Simon R; Grupp K; Gerig CY; Bär D; Robinson MD; Baer C; Weiss M; Gu Z; Schapira M; Kuner R; Sültmann H; Provenzano M; ; Yaspo ML; Brors B; Korbel J; Schlomm T; Sauter G; Eils R; Plass C; Santoro R Nat Genet; 2015 Jan; 47(1):22-30. PubMed ID: 25485837 [TBL] [Abstract][Full Text] [Related]
5. Sodium arsenite exposure enhances H3K14 acetylation and impairs male spermatogenesis in rat testes. Li X; Shen K; Yuan D; Fan J; Yang Y; Tian F; Quan J; Li C; Wang J Reprod Toxicol; 2023 Dec; 122():108474. PubMed ID: 37757915 [TBL] [Abstract][Full Text] [Related]
8. CUL4B regulates cancer stem-like traits of prostate cancer cells by targeting BMI1 via miR200b/c. Jiao M; Qi M; Zhang F; Hu J; Feng T; Zhao M; Li X; Liu H; Teng W; Zhang J; Liu Z; Zhang L; Wu Z; Han B Prostate; 2019 Aug; 79(11):1294-1303. PubMed ID: 31111526 [TBL] [Abstract][Full Text] [Related]
9. NFATc1 promotes prostate tumorigenesis and overcomes PTEN loss-induced senescence. Manda KR; Tripathi P; Hsi AC; Ning J; Ruzinova MB; Liapis H; Bailey M; Zhang H; Maher CA; Humphrey PA; Andriole GL; Ding L; You Z; Chen F Oncogene; 2016 Jun; 35(25):3282-92. PubMed ID: 26477312 [TBL] [Abstract][Full Text] [Related]
10. Pan-cancer and multi-omics analyses revealed the diagnostic and prognostic value of BAZ2A in liver cancer. Liu Y; Wang J; Guo J; Zhang Q; Wang S; Hu F; Wu J; Zhao Y; Zhang J; Yu Y; Li Y; Zhang X Sci Rep; 2024 Mar; 14(1):5228. PubMed ID: 38433277 [TBL] [Abstract][Full Text] [Related]
11. Discovery of BAZ2A bromodomain ligands. Spiliotopoulos D; Wamhoff EC; Lolli G; Rademacher C; Caflisch A Eur J Med Chem; 2017 Oct; 139():564-572. PubMed ID: 28837921 [TBL] [Abstract][Full Text] [Related]
12. Structural basis of the TAM domain of BAZ2A in binding to DNA or RNA independent of methylation status. Chen S; Zhou M; Dong A; Loppnau P; Wang M; Min J; Liu K J Biol Chem; 2021 Dec; 297(6):101351. PubMed ID: 34715126 [TBL] [Abstract][Full Text] [Related]
13. ZMYND8 Reads the Dual Histone Mark H3K4me1-H3K14ac to Antagonize the Expression of Metastasis-Linked Genes. Li N; Li Y; Lv J; Zheng X; Wen H; Shen H; Zhu G; Chen TY; Dhar SS; Kan PY; Wang Z; Shiekhattar R; Shi X; Lan F; Chen K; Li W; Li H; Lee MG Mol Cell; 2016 Aug; 63(3):470-84. PubMed ID: 27477906 [TBL] [Abstract][Full Text] [Related]
14. MicroRNAs and epithelial-mesenchymal transition in prostate cancer. Sekhon K; Bucay N; Majid S; Dahiya R; Saini S Oncotarget; 2016 Oct; 7(41):67597-67611. PubMed ID: 27588490 [TBL] [Abstract][Full Text] [Related]
15. Structural Analysis of Small-Molecule Binding to the BAZ2A and BAZ2B Bromodomains. Dalle Vedove A; Spiliotopoulos D; D'Agostino VG; Marchand JR; Unzue A; Nevado C; Lolli G; Caflisch A ChemMedChem; 2018 Jul; 13(14):1479-1487. PubMed ID: 29770599 [TBL] [Abstract][Full Text] [Related]
16. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis. Lee E; Wang J; Yumoto K; Jung Y; Cackowski FC; Decker AM; Li Y; Franceschi RT; Pienta KJ; Taichman RS Neoplasia; 2016 Sep; 18(9):553-66. PubMed ID: 27659015 [TBL] [Abstract][Full Text] [Related]
17. Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2'-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis. Tian J; Lee SO; Liang L; Luo J; Huang CK; Li L; Niu Y; Chang C J Biol Chem; 2012 Nov; 287(47):39954-66. PubMed ID: 23012352 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway. Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675 [TBL] [Abstract][Full Text] [Related]
19. H3K9 and H3K14 acetylation co-occur at many gene regulatory elements, while H3K14ac marks a subset of inactive inducible promoters in mouse embryonic stem cells. Karmodiya K; Krebs AR; Oulad-Abdelghani M; Kimura H; Tora L BMC Genomics; 2012 Aug; 13():424. PubMed ID: 22920947 [TBL] [Abstract][Full Text] [Related]
20. THBS4 silencing regulates the cancer stem cell-like properties in prostate cancer via blocking the PI3K/Akt pathway. Hou Y; Li H; Huo W Prostate; 2020 Jul; 80(10):753-763. PubMed ID: 32421868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]